What happens in the body when a person with celiac disease eats gluten

Short answer

In celiac disease, gluten sets off an immune reaction that damages the small intestine2. How much a person feels it ranges from very mild to severe19, and in one challenge study some people who developed significant intestinal damage had no symptoms25.

Published by Gluten Verdict · updated · 11 sources, each linked below

Reviewed by Mark Peter, Registered dietitian (RD), on

A person seen from behind sits on a bed holding a mug with water nearby

Key points

  • Gluten triggers an abnormal immune reaction that damages the small intestine2; the review in BMC Medicine ties it to blunted villi and the death of intestinal lining cells4.
  • Symptoms vary from person to person, from very mild to severe19.
  • In a 14-day challenge, symptom scores had no significant correlation with the biopsy and antibody measures, apart from one antibody link22.
  • In a 12-week challenge, 22% of those who developed significant small-intestinal damage had no symptoms25.
  • In one small study of everyday exposure on a gluten-free diet, most exposures were asymptomatic and unsuspected37.

What gluten sets off in the body

NIDDK describes celiac disease as a chronic digestive and immune disorder that damages the small intestine and is triggered by eating foods containing gluten1. In people who have it, consuming gluten triggers an abnormal immune system reaction that damages the small intestine2.

Coeliac UK names the target as the lining of the gut (the villi), where food and nutrients are absorbed3. A 2019 review in BMC Medicine gives a closer view: when CD4+ T cells in the lamina propria meet gluten they are activated and multiply, and the review ties that to crypt overgrowth and blunted villi, secondary to the death of intestinal lining cells induced by intraepithelial lymphocytes (IELs)4.

What the studies measured in the lining of the small intestine

The first study below is a challenge study, in which adults with celiac disease ate a measured amount of gluten and were then assessed. In it, 20 adults with biopsy-proven coeliac disease ate 3 or 7.5 grams of gluten a day for 14 days5. Between the start and day 14, the villous height to crypt depth ratio (Vh:Cd) fell from 2.2 to 1.1 and the intraepithelial lymphocyte (IEL) measure rose from 32.6 to 51.86.

The authors concluded that 14 days at 3 grams of gluten a day or more induces histological and serological changes in the majority of adults with coeliac disease7.

Those doses were grams a day, for two weeks. The exposures measured outside the lab in the study further down this page were typically in the milligram range8. The sources used here do not translate a challenge dose into a crumb.

What one large dose looked like in two trials

Two trials followed the hours after a single dose of about 6 grams of gluten in people with coeliac disease on a gluten-free diet. In the first, 25 people with coeliac disease and 25 healthy volunteers ate a standardised 6 gram gluten challenge9. Symptoms began after 1 hour and peaked in the third. Nausea and vomiting characterised severe reactions, while mild reactions were limited to headache and tiredness10. A blood marker, serum interleukin-2, was undetectable at baseline and above 0.5 pg/ml at 4 hours in 92% of the coeliac patients; it was always undetectable in the healthy controls11.

The second trial used 36 coeliac disease patients who had received placebo in a larger study. Each had a double-blind bolus of vital wheat gluten (about 6 grams of gluten protein) and, two weeks apart, a sham challenge low in FODMAPs12. Nausea (6% after sham, 61% after gluten) and vomiting (0% and 44%) were the only adverse events more common with gluten than with sham, with a median onset of 1:34 hours for nausea and 1:51 hours for vomiting13. The authors concluded that nausea and vomiting are relatively specific indicators of acute gluten ingestion and correlate with immune activation14.

Limits. Both used a single test dose of about 6 grams, and one reaction in a trial is not a script for every person. The authors of the second trial write that FODMAPs in gluten-containing foods, and participant anticipation of a harmful ("nocebo") effect, may contribute to acute symptoms after gluten challenge15. The abstracts list ImmusanT, Inc. among the authors' affiliations16, 17.

Why symptoms and damage do not always match

NIDDK says symptoms of celiac disease vary widely, and that a person may have several that come and go18. Coeliac UK says they range from very mild to severe19. NIDDK adds that some people have symptoms that affect other parts of the body20.

Two challenge studies show how feeling and damage can come apart22, 25. In the 14-day study, gastrointestinal symptoms rose significantly by day 3 and were back at baseline by day 2821. Apart from one link between the change in a symptom score and one antibody titre, the authors found no other significant correlation between symptoms, or change in symptoms, and the biopsy measures or antibody levels22.

In a 12-week study, 25 adults ate 1 to 3 grams or 3 to 5 grams of gluten a day23. Both low and moderate amounts induced small-bowel morphological damage in 67% of patients24. In 22% of those who developed significant small-intestinal damage, symptoms remained absent25.

NIDDK states that people with celiac disease who have no symptoms can still develop complications over time if they do not get treatment26.

Why reactions differ between people

The sources used here give no rule for predicting a given person's reaction. These are the differences they report:

  • Amount, in the short term. In the 14-day study, no differences were seen between the 3 and 7.5 gram doses21. In the 12-week study, moderate doses (3 to 5 grams) also triggered mucosal inflammation and more symptoms, leading to premature withdrawals in seven cases23, 27.
  • Small amounts, repeated. In a 90-day trial in 49 adults treated with a gluten-free diet28, patients took a daily capsule with 0, 10 or 50 mg of gluten29. One patient on 10 mg developed a clinical relapse, and the percentage change in Vh/Cd was 9% with placebo, -1% on 10 mg (95% CI -18%, 68%) and -20% on 50 mg (95% CI -22%, -13%)30.
  • Age. NIDDK says digestive symptoms are more common in children than in adults31.
  • Form of the disease. The 2019 review describes a subclinical form, with symptoms or signs below the clinical identification threshold, often recognizable only once the benefit of a gluten-free diet is seen32.
  • The person's own pattern, which can change. The authors of the 12-week study note that some patients did not respond on any measure during the challenge33. They write that it is well known that celiac patients show varying sensitivity to gluten and that mucosal deterioration may take years or even decades34, and that the phenotype of the disease may vary in the same person over time35.

What one study found about everyday exposure on a gluten-free diet

A study followed adults with coeliac disease on a gluten-free diet for 10 days36. Twelve of the 18 had a median of 2.1 mg of gluten per exposure (range 0.2 to more than 80 mg), and most exposures were asymptomatic and unsuspected37. The authors concluded that exposure on a gluten-free diet is common, intermittent and usually silent38.

NIDDK says some other products can be hidden sources of gluten: a person may take in small amounts by consuming them, using them around the mouth, or transferring them from hands to mouth by accident39. Our guides on hidden sources of gluten and cross-contamination cover where those small amounts come from.

One small study. Its authors call their findings likely a "best case" because participants were highly engaged and had access to dietitians with gluten-free diet expertise40.

What the sources say about repeated exposure and follow-up

NIDDK says symptoms typically improve and may go away on a gluten-free diet, and may return if a person consumes small amounts of gluten41.

It reports that in about 20 percent of people with celiac disease, symptoms continue or come back on a gluten-free diet, and lists small amounts of gluten, other health problems and refractory celiac disease as possible causes42.

NIDDK says follow-up may include antibody blood tests, which are higher in untreated celiac disease but typically return to normal after treatment, and in some cases biopsies to find out whether the small intestine has healed43. The 14-day challenge study adds a timing detail: antibody titres rose only slightly by day 14 and markedly by day 2844.

Questions people ask

Can someone with celiac disease have no symptoms and still be affected?

In a 12-week challenge study, 22% of those who developed significant small-intestinal damage had no symptoms25. NIDDK says people with celiac disease who have no symptoms can still develop complications over time if they do not get treatment26.

Do small amounts of gluten matter?

NIDDK says symptoms may return if a person consumes small amounts of gluten41. In one 90-day trial, the percentage change in Vh/Cd was -20% in the group taking 50 mg a day, against 9% with placebo30. This guide does not set an amount that applies to everyone; the 90-day trial is one study.

Is this the same as a wheat allergy or gluten sensitivity?

NIDDK describes them as different conditions: wheat allergies do not cause long-term damage to the small intestine45, and unlike celiac disease, gluten sensitivity does not damage the small intestine46.

More in Symptoms, reactions and persistent complaints

Sources